BDNF Heterozygous Mice Phenotyping
Objective: Assessment of eating behavior and locomotor activity abnormalities in heterozygous BDNF mutant mice to determine BDNF's role in regulating eating behavior and locomotor activity
This is a BDNF Heterozygous Mice Phenotyping protocol using mouse as the model organism. The procedure involves 3 procedural steps, 2 materials. Extracted from a 2000 paper published in The EMBO Journal.
Model and subjects
mouse • BDNF heterozygous mutant mice (inbred and hybrid strains mentioned) • Not specified • Not specified • Not specified • Not specified
Study window
Estimated timing pending
Core workflow
Phenotypic Assessment of Heterozygous BDNF Mice • Validation in Multiple Strains • Neurotrophin Infusion Treatment
Primary readouts
- Eating behavior abnormalities
- Locomotor activity abnormalities
- Obesity phenotype
- Response to BDNF or NT4/5 infusion
Key equipment and reagents
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Phenotypic Assessment of Heterozygous BDNF Mice
Evaluate heterozygous BDNF mutant mice for abnormalities in eating behavior and locomotor activity
Note: All heterozygous mice exhibited abnormalities in eating behavior or locomotor activity
View evidence from paper
“In heterozygous mice, BDNF gene expression is reduced and we find that all heterozygous mice exhibit abnormalities in eating behavior or locomotor activity”
Validation in Multiple Strains
Confirm phenotype in independently derived inbred and hybrid BDNF mutant strains
Note: Phenotype was observed across multiple independently derived strains
View evidence from paper
“We also observe this phenotype in independently derived inbred and hybrid BDNF mutant strains”
Neurotrophin Infusion Treatment
Infuse BDNF or NT4/5 to assess reversal of eating behavior abnormalities and obesity
Note: Treatment produced transient reversal of phenotype
View evidence from paper
“Infusion with BDNF or NT4/5 can transiently reverse the eating behavior and obesity”